BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/27/2017 6:19:00 PM | Browse: 1246 | Download: 1864
 |
Received |
|
2016-08-20 14:13 |
 |
Peer-Review Started |
|
2016-08-23 14:22 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2016-10-21 10:54 |
 |
Revised |
|
2016-11-02 19:45 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2016-11-17 16:47 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2016-11-29 08:55 |
 |
Articles in Press |
|
2016-11-29 08:55 |
 |
Edit the Manuscript by Language Editor |
|
2016-12-05 10:07 |
 |
Typeset the Manuscript |
|
2017-02-23 10:27 |
 |
Publish the Manuscript Online |
|
2017-02-27 18:20 |
| ISSN |
1949-8470 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Radiology, Nuclear Medicine & Medical Imaging |
| Manuscript Type |
Editorial |
| Article Title |
Evaluation of response to immune checkpoint inhibitors: Is there a role for positron emission tomography?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Matteo Bauckneht, Roberta Piva, Gianmario Sambuceti, Francesco Grossi and Silvia Morbelli |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Silvia Morbelli, MD, PhD, Nuclear Medicine Unit, IRCCS San Martino-IST, University of Genoa, Largo R. Benzi 10, 16132 Genova,
Italy. silviadaniela.morbelli@hsanmartino.it
|
| Key Words |
Immune checkpoint inhibitors; Positron emission tomography; Computed tomography; 18F-fluoro-2-deoxy-D-glucose; Non-18F-fluoro-2-deoxy-D-glucose tracers |
| Core Tip |
In the clinical practice, the radiological interpretation of immunotherapy effects represents a huge challenge at single patient level. However, although the computed tomography-based response evaluation for immune checkpoint inhibitors (ICPIs) is feasible thanks to the introduction of immune-related response criteria, very few data are available for the potential role of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET). Due to the intrinsic nature of FDG accumulation pathophysiology, it might be central to test the complex and variegated response to ICPIs by means of PET. Finally, PET might offer a new insight into the biology of ICPIs thanks to a growing number of non-invasive immune-diagnostic approaches based on non-FDG tracers.
|
| Publish Date |
2017-02-27 18:20 |
| Citation |
Bauckneht M, Piva R, Sambuceti G, Grossi F, Morbelli S. Evaluation of response to immune checkpoint inhibitors: Is there a role for positron emission tomography? World J Radiol 2017; 9(2): 27-33 |
| URL |
http://www.wjgnet.com/1949-8470/full/v9/i2/27.htm |
| DOI |
http://dx.doi.org/10.4329/wjr.v9.i2.27 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.